Literature DB >> 24759793

Transcriptome complexity in cardiac development and diseases--an expanding universe between genome and phenome.

Chen Gao1, Yibin Wang.   

Abstract

With the advancement of transcriptome profiling by micro-arrays and high-throughput RNA-sequencing, transcriptome complexity and its dynamics are revealed at different levels in cardiovascular development and diseases. In this review, we will highlight the recent progress in our knowledge of cardiovascular transcriptome complexity contributed by RNA splicing, RNA editing and noncoding RNAs. The emerging importance of many of these previously under-explored aspects of gene regulation in cardiovascular development and pathology will be discussed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24759793      PMCID: PMC4306672          DOI: 10.1253/circj.cj-14-0412

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  150 in total

1.  The Sam68 STAR RNA-binding protein regulates mTOR alternative splicing during adipogenesis.

Authors:  Marc-Étienne Huot; Gillian Vogel; Amber Zabarauskas; Chau Tuan-Anh Ngo; Jasmin Coulombe-Huntington; Jacek Majewski; Stéphane Richard
Journal:  Mol Cell       Date:  2012-03-15       Impact factor: 17.970

Review 2.  A new level of complexity: the role of microRNAs in cardiovascular development.

Authors:  Thomas Boettger; Thomas Braun
Journal:  Circ Res       Date:  2012-03-30       Impact factor: 17.367

Review 3.  MicroRNAs in control of cardiac hypertrophy.

Authors:  Paula A Da Costa Martins; Leon J De Windt
Journal:  Cardiovasc Res       Date:  2012-01-19       Impact factor: 10.787

4.  Developmentally regulated SCN5A splice variant potentiates dysfunction of a novel mutation associated with severe fetal arrhythmia.

Authors:  Lisa L Murphy; Anita J Moon-Grady; Bettina F Cuneo; Ronald T Wakai; Suhong Yu; Jennifer D Kunic; D Woodrow Benson; Alfred L George
Journal:  Heart Rhythm       Date:  2011-11-07       Impact factor: 6.343

5.  Systematic identification of long noncoding RNAs expressed during zebrafish embryogenesis.

Authors:  Andrea Pauli; Eivind Valen; Michael F Lin; Manuel Garber; Nadine L Vastenhouw; Joshua Z Levin; Lin Fan; Albin Sandelin; John L Rinn; Aviv Regev; Alexander F Schier
Journal:  Genome Res       Date:  2011-11-22       Impact factor: 9.043

6.  Expression of the translational repressor NAT1 in experimental models of cardiac hypertrophy.

Authors:  S Jeson Sangaralingham; Brian J Pak; M Yat Tse; Ekaterini Angelis; Michael A Adams; C Smallegange; Stephen C Pang
Journal:  Mol Cell Biochem       Date:  2003-03       Impact factor: 3.396

7.  Involvement of a chaperone regulator, Bcl2-associated athanogene-4, in apolipoprotein B mRNA editing.

Authors:  Paul P Lau; Lawrence Chan
Journal:  J Biol Chem       Date:  2003-10-13       Impact factor: 5.157

8.  A muscleblind knockout model for myotonic dystrophy.

Authors:  Rahul N Kanadia; Karen A Johnstone; Ami Mankodi; Codrin Lungu; Charles A Thornton; Douglas Esson; Adrian M Timmers; William W Hauswirth; Maurice S Swanson
Journal:  Science       Date:  2003-12-12       Impact factor: 47.728

9.  Dilated cardiomyopathy caused by tissue-specific ablation of SC35 in the heart.

Authors:  Jian-Hua Ding; Xiangdong Xu; Dongmei Yang; Pao-Hsien Chu; Nancy D Dalton; Zhen Ye; Joanne M Yeakley; Heping Cheng; Rui-Ping Xiao; John Ross; Ju Chen; Xiang-Dong Fu
Journal:  EMBO J       Date:  2004-02-12       Impact factor: 11.598

10.  SAM68: a downstream target of angiotensin II signaling in vascular smooth muscle cells in genetic hypertension.

Authors:  Mohammed El Mabrouk; Quy N Diep; Karim Benkirane; Rhian M Touyz; Ernesto L Schiffrin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-12-23       Impact factor: 4.733

View more
  1 in total

1.  Differential expression of members of SOX family of transcription factors in failing human hearts.

Authors:  Chia-Feng Liu; Ying Ni; Varun Thachil; Michael Morley; Christine S Moravec; Wai Hong Wilson Tang
Journal:  Transl Res       Date:  2021-10-22       Impact factor: 7.012

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.